Table 3 Seasonality of pulmonary (PTB) and extrapulmonary tuberculosis (EPTB) by gender and age.
Age group | Gender | Pulmonary Tuberculosis | Extrapulmonary Tuberculosis | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Continuous wavelet transform (power spectrum) | Dynamic generalised linear regression | Continuous wavelet transform (power spectrum) | Dynamic generalised linear regression | ||||||||||
Globala | Localb | Seasonal amplitude (peak-to-tough ratio) | Peak timing in year (months) | Globala | Localb | Seasonal amplitude (peak-to-tough ratio) | Peak timing (months) | ||||||
Elderly (≥ 65) | Male | * | 2005–2012 | 1.22 (1.13–1.33) | 1.16 (1.12–1.24) | 6.42 (5.96–6.82) | 6.31 (5.85–6.80) | – | – | – | – | – | – |
Female | – | – | – | – | – | – | * | 2009–2012; & 2014–2017 | 1.64 (1.50–2.22) | 1.64 (1.45–1.91) | 7.56 (7.11–8.09) | 7.56 (6.97–8.01) | |
Middle aged (45–64) | Male | * | 2005–2008; & 2012 | 1.16 (1.08–1.28) | 1.16 (1.08–1.24) | 6.65 (5.94–7.56) | 6.65 (5.84–7.35) | * | 2013–2015 | 1.33 (1.07–1.52) | 1.22 (1.10–1.67) | 7.52 (5.01–8.20) | 5.44 (5.06–8.11) |
Female | * | 2005–2013 | 1.33 (1.27–1.58) | 1.33 (1.24–1.48) | 7.50 (6.93–8.11) | 7.49 (7.01–8.06) | * | 2012–2015 | 1.28 (1.17–1.44) | 1.28 (1.18–1.45) | 6.60 (5.87–7.33) | 6.60 (5.90–7.33) | |
Adult (30–44) | Male | – | – | – | – | – | – | – | – | – | – | – | – |
Female | * | 2005–2007; &2011–2014 | 1.29 (1.20–1.40) | 1.29 (1.20–1.39) | 6.91 (6.33–7.37) | 6.91 (6.34–7.36) | * | 2005–2008 | 1.93 (1.13–2.10) | 1.24 (1.09–1.59) | 7.03 (4.17–7.13) | 4.39 (3.93–7.66) | |
Youngadults (15–29) | Male | * | 2005–2006; and 2013 | 1.18 (1.10–1.29) | 1.18 (1.10–1.30) | 7.14 (6.22–7.89) | 7.14 (6.15–7.93) | * | 2007–2008; and 2010–2013 | 1.48 (1.25–1.90) | 1.22 (1.18–1.90) | 8.14 (5.98–8.41) | 5.79 (4.75–8.11) |
Female | * | 2005–2007 | 1.28 (1.16–1.38) | 1.28 (1.16–1.38) | 7.13 (6.43–7.74) | 7.13 (6.45–7.74) | * | 2005; 2009 | 1.39 (1.16–1.72) | 1.34 (1.15–1.69) | 5.82 (4.75–6.90) | 5.80 (4.62–7.00) | |
Children (0–14) | Male | – | – | – | – | – | – | – | – | – | – | – | – |
Female | – | – | – | – | – | – | – | – | – | – | – | – |